Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10669253 Methods to induce targeted protein degradation through bifunctional molecules

Patent 10669253 was granted and assigned to Dana-Farber Cancer Institute on June, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 13 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11752197 Macrophage stimulating 1 receptor (MST1R) variants and uses thereof
Edits on 7 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Jun, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11667628 Compounds for imaging tau proteins that accumulate in brain
0
Edits on 18 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 18 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=106692530
Edits on 10 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 10 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11642413 Compounds for degrading Tau protein aggregates and uses thereof
0
Edits on 23 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
106692530
Date of Patent
June 2, 2020
0
Patent Application Number
161670910
Date Filed
October 22, 2018
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=106692530
Patent Citations
‌
US Patent 10239888 Targeted protein degradation using a mutant E3 ubiquitin ligase
0
Patent Citations Received
‌
US Patent 11291732 Compounds for degrading α-synuclein aggregates and uses thereof
0
Patent Primary Examiner
‌
Jeffrey H Murray
0
Edits on 21 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 21 Mar, 2023
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 24 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10669253
Edits on 6 Apr, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11291732 Compounds for degrading α-synuclein aggregates and uses thereof
Edits on 4 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 4 Feb, 2022
Edits made to:
Infobox (+10 properties)
‌

 US Patent 10669253 Methods to induce targeted protein degradation through bifunctional molecules

Infobox
Is a
Patent
Patent
Patent applicant
Current assignee
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10669253
Date of patent
June 2, 2020
Patent application number
16167091
Date Filed
October 22, 2018
Patent citations
‌
US Patent 10239888 Targeted protein degradation using a mutant E3 ubiquitin ligase
Patent primary examiner
‌
Jeffrey H Murray

Find more entities like US Patent 10669253 Methods to induce targeted protein degradation through bifunctional molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo